Should Patients With a Large Local Reaction Be Offered Venom Immunotherapy? A Pro-Con Debate.

Area of Science:

• Allergy and Immunology
• Toxicology

Background:

• Insect stings frequently cause large local reactions (LLRs), which are IgE-mediated immune responses.
• LLRs can lead to significant patient morbidity and reduced quality of life.
• A potential risk of systemic reactions, including anaphylaxis, to future stings exists.

Purpose of the Study:

• To review the current evidence and debate regarding the use of venom immunotherapy (VIT) for patients experiencing LLRs.
• To evaluate the risks and benefits of VIT in the context of LLRs.
• To inform clinical decision-making for managing insect sting LLRs.

Main Methods:

• Literature review and critical analysis of existing studies on insect sting reactions and venom immunotherapy.
• Examination of data concerning the incidence of anaphylaxis following LLRs.
• Discussion of the pros and cons of VIT for LLRs, considering safety, efficacy, and patient factors.

Main Results:

• Current guidelines do not recommend VIT for LLRs due to a perceived low risk of anaphylaxis.
• Arguments for VIT include potentially underestimated anaphylaxis risk, emerging potent sting species, and significant quality of life impairment from LLRs.
• Arguments against VIT include the generally benign nature of LLRs, infrequent sting occurrences, VIT costs, and higher systemic reaction rates to VIT compared to stings in LLR patients.

Conclusions:

• The decision to use VIT for LLRs is complex and should involve shared decision-making between patient and healthcare provider.
• Consideration of individual patient values, preferences, and risk factors is crucial.
• Further research may be needed to clarify the precise risk of anaphylaxis in specific LLR patient populations.